Chris Chumsae, PhD
About Chris Chumsae, PhD
Chris Chumsae, PhD, is the Director of Analytical Development at Bristol Myers Squibb in Devens, MA, with extensive experience in analytical and protein chemistry.
Company
Chris Chumsae currently holds the position of Director of Analytical Development at Bristol Myers Squibb, located in Devens, MA. Since joining the company in March 2020, he has been leading innovation and advancements in analytical methodologies, particularly focusing on non-platform analytics and process analytical technologies (PAT).
Title
Chris Chumsae is the Director of Analytical Development at Bristol Myers Squibb, where he oversees analytical strategy and innovation efforts. In this role, he leverages his extensive experience in protein chemistry and liquid chromatography-mass spectrometry (LC-MS).
Education and Expertise
Chris Chumsae completed his undergraduate studies at Assumption College, earning a BA in Chemistry. He then pursued graduate coursework in Biotechnology at Worcester State College, achieving an MS. At Northeastern University, he obtained an MS in Chemistry and later a PhD in Chemistry, completing his doctoral studies in 2015. His expertise includes LC-MS, protein chemistry, and method development within the pharmaceutical industry.
Work Background
Chris Chumsae has a substantial background in analytical chemistry and protein chemistry. Before his current role at Bristol Myers Squibb, he spent 19 years at AbbVie Bioresearch Center in Worcester, MA, as a Principal Research Scientist I. Additionally, he has held positions such as Senior Applications Chemist at Waters and Analytical Protein Chemist at Creative Biomolecules. His early career included roles as an Associate Scientist at Hybridon, Inc, an Associate Research Scientist at the Institute of Molecular Biology, and a Research Associate at Cambridge Biotechnology Ltd.
Achievements
During his tenure at AbbVie Bioresearch Center, Chris Chumsae made significant contributions as a Principal Research Scientist I. At Bristol Myers Squibb, he has been leading teams focused on enhancing non-platform analytics and process analytical technologies (PAT). His work in liquid chromatography-mass spectrometry (LC-MS) and protein chemistry is well-regarded in the pharmaceutical industry.